A NAD+ 1000mg & Retatrutide: The UK Advance in Cellular Function
Emerging data from the UK are generating considerable excitement surrounding the potential synergy of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unusual approach aims to improve multiple facets of metabolic dysfunction , potentially offering a